Ovarian cysts and cancer in pregnancy

Best Pract Res Clin Obstet Gynaecol. 2016 May:33:58-72. doi: 10.1016/j.bpobgyn.2015.10.015. Epub 2015 Oct 30.

Abstract

Adnexal masses are diagnosed in 5% pregnancies and pose diagnostic and management challenges. Ultrasound and magnetic resonance imaging (MRI) are the mainstay as an evaluation procedure; surgery is warranted for persistent masses with a diameter of >5 cm and sonographic signs of possible malignancy. Optimal timing for a planned surgery is the second trimester and does not adversely affect neonatal outcome. Laparoscopy is safe in pregnancy. Management for ovarian cancer during pregnancy should be individualised and formulated by a multidisciplinary team in a specialised centre while also considering the patients' wishes to preserve pregnancy. The following options can be considered: (i) induced abortion followed by standard management of ovarian cancer, (ii) pregnancy-preserving surgery followed by chemotherapy, planned delivery and secondary surgical completion or (iii) neoadjuvant chemotherapy followed by surgery during the postpartum period. Standard chemotherapy administered in non-pregnant population can only be used during the first trimester of pregnancy.

Keywords: ovarian cancer; ovarian cyst; pregnancy.

MeSH terms

  • Antineoplastic Agents / administration & dosage
  • Biomarkers, Tumor / blood
  • Female
  • Gestational Age
  • Humans
  • Laparoscopy
  • Magnetic Resonance Imaging
  • Ovarian Cysts / complications
  • Ovarian Cysts / diagnostic imaging*
  • Ovarian Cysts / pathology
  • Ovarian Cysts / therapy*
  • Ovarian Neoplasms / complications
  • Ovarian Neoplasms / diagnostic imaging*
  • Ovarian Neoplasms / pathology
  • Ovarian Neoplasms / therapy*
  • Ovariectomy
  • Perioperative Care
  • Pregnancy
  • Pregnancy Complications, Neoplastic / diagnostic imaging*
  • Pregnancy Complications, Neoplastic / pathology
  • Pregnancy Complications, Neoplastic / therapy*
  • Salpingectomy
  • Ultrasonography

Substances

  • Antineoplastic Agents
  • Biomarkers, Tumor